Home › Trials › NCT06194045
Clinical trial No longer in our active list Interventional Ages 18 to 80

Effect of Fish Oil on Atopic Dermatitis

Official title: A Randomized, Double-blinded Nutritional Study to Determine the Effect of a Concentrated Cetoleic Acid Fish Oil on Atopic Dermatitis

Run by Møreforsking AS · NCT06194045 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing if a fish oil supplement can help people with mild to moderate eczema improve their skin condition over six months.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment60 (estimated)
SponsorMøreforsking AS
Academic / other
Locations1 site (Ålesund, Møre Og Romsdal)
Trial IDNCT06194045 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are men and women aged 18-80 with a diagnosis of active mild to moderate atopic dermatitis.

Probably not a fit

Patients with known allergies to fish products or those with other skin diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of cetoleic acid, a long-chain monounsaturated fatty acid found in fish oil, on individuals with mild to moderate atopic dermatitis. Participants will be randomly assigned to receive either cetoleic-rich fish oil or a placebo for a duration of six months. The study aims to assess changes in skin condition and inflammation levels before, during, and after the intervention. By examining the lipid composition and microbiome changes, the research seeks to understand the potential benefits of cetoleic acid in managing atopic dermatitis.

Why it matters

Potential benefit: If successful, this study could provide a new dietary approach to effectively manage and alleviate symptoms of atopic dermatitis.

How similar studies have gone: Previous studies have indicated an anti-inflammatory effect of cetoleic acid, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Women and men 18-80 years of age.
* Diagnosed with active mild to moderate atopic dermatitis with an EASI of 1.1- 21.0.
* Willing to refrain from oil supplements (omega-3, borage, evening primrose, etc.) for 1 month before study begin (washout) and during the study
* Willing to take the study supplement for 6 months

Exclusion Criteria:

* Known allergy to fish products
* Subjects known to be pregnant or breast feeding
* Subjects perceiving systemically administered medication for AD (other than topical)
* Subjects with auto-immune diseases (except asthma and seasonal/perennial rhinitis)
* Subjects with a diagnosis of other skin diseases

Where it's running

  • Helse Møre og Romsdal HF
    Ålesund, Møre Og Romsdal, Norway     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Atopic Dermatitis 166
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.